trial · primary record
Benralizumab
Asthma
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 94 |
| Primary completion | 2026-12-23 |
| Primary endpoint | Time to first asthma exacerbation |
| Registry ID | NCT05692180 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:20.404Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05692180
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- BENRALIZUMAB · approval
- Benralizumab · compound